DK0477971T3 - Humant CNP gen og precursorprotein - Google Patents

Humant CNP gen og precursorprotein

Info

Publication number
DK0477971T3
DK0477971T3 DK91116557T DK91116557T DK0477971T3 DK 0477971 T3 DK0477971 T3 DK 0477971T3 DK 91116557 T DK91116557 T DK 91116557T DK 91116557 T DK91116557 T DK 91116557T DK 0477971 T3 DK0477971 T3 DK 0477971T3
Authority
DK
Denmark
Prior art keywords
precursor protein
human cnp
human
cnp gene
gene
Prior art date
Application number
DK91116557T
Other languages
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Shoji Tanaka
Kayoko Fuchimura
Yasunori Tawaragi
Naoto Minamino
Original Assignee
Hisayuki Matsuo
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo
Application granted granted Critical
Publication of DK0477971T3 publication Critical patent/DK0477971T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK91116557T 1990-09-27 1991-09-27 Humant CNP gen og precursorprotein DK0477971T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02259698A JP3026354B2 (ja) 1990-09-27 1990-09-27 ヒトｃｎｐ遺伝子及び前駆体蛋白

Publications (1)

Publication Number Publication Date
DK0477971T3 true DK0477971T3 (da) 1998-09-21

Family

ID=17337688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91116557T DK0477971T3 (da) 1990-09-27 1991-09-27 Humant CNP gen og precursorprotein

Country Status (8)

Country Link
US (1) US6034231A (da)
EP (2) EP0769554B1 (da)
JP (1) JP3026354B2 (da)
AT (2) ATE388165T1 (da)
DE (2) DE69133593T2 (da)
DK (1) DK0477971T3 (da)
ES (2) ES2302333T3 (da)
GR (1) GR3026554T3 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
AU2003297583B2 (en) 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
ES2465141T3 (es) * 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
EP3446711A1 (en) 2004-03-31 2019-02-27 Kazuwa Nakao Composition for increasing body height
PL3404102T3 (pl) 2004-04-21 2021-12-13 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
US20080207505A1 (en) * 2005-01-12 2008-08-28 James Kenneth D Bna Conjugates and Methods of Use
US20070184466A1 (en) * 2005-11-18 2007-08-09 The Brigham And Women's Hospital, Inc. Detection, generation and uses of atherosclerosis-protective endothelium
AU2008326327A1 (en) * 2007-11-21 2009-05-28 Biomarin Pharmaceutical Inc. Variants of C-type natriuretic peptide
JP5524049B2 (ja) * 2008-05-23 2014-06-18 第一三共株式会社 目的ペプチドの血漿中半減期延長作用を有するペプチド
MX2011012277A (es) * 2009-05-20 2011-12-12 Biomarin Pharm Inc Variantes de peptidos natriureticos de tipo c.
CA2823066A1 (en) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
CA2852874A1 (en) 2011-10-19 2013-04-25 Alexion Pharma Holding Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
RU2708068C2 (ru) 2014-12-05 2019-12-04 Алексион Фармасьютикалз, Инк. Лечение судорог с использованием рекомбинантной щелочной фосфатазы
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
KR20180030414A (ko) 2015-07-30 2018-03-22 바이오마린 파머수티컬 인크. 골 이형성증 치료를 위한 c―형 나트륨이뇨 펩타이드 변이체의 용도
CN108350440A (zh) 2015-08-17 2018-07-31 阿雷克森制药公司 碱性磷酸酯的制造
EP3355904A4 (en) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3436052A4 (en) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. TREATMENT OF MUSCLE WEAKNESS USING ALKALINE PHOSPHATASES
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
US11224637B2 (en) 2017-03-31 2022-01-18 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia (HPP) in adults and adolescents
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
MX2022003184A (es) 2019-09-16 2022-06-23 Biomarin Pharm Inc Variantes del cnp y sus conjugados.
WO2023283657A1 (en) 2021-07-09 2023-01-12 Biomarin Pharmaceutical Inc. C-type natriuretic peptide variants to treat skeletal dysplasia in children
WO2023108005A1 (en) 2021-12-07 2023-06-15 Biomarin Pharmaceutical Inc. C-type natriuretic peptide therapy of bone-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
DE69128754T2 (de) 1998-06-04
JP3026354B2 (ja) 2000-03-27
EP0769554A2 (en) 1997-04-23
JPH04139199A (ja) 1992-05-13
EP0477971A3 (en) 1992-09-09
US6034231A (en) 2000-03-07
ES2302333T3 (es) 2008-07-01
ES2113865T3 (es) 1998-05-16
DE69133593D1 (de) 2008-04-17
EP0477971B1 (en) 1998-01-21
ATE162532T1 (de) 1998-02-15
DE69133593T2 (de) 2009-04-02
DE69128754D1 (de) 1998-02-26
EP0477971A2 (en) 1992-04-01
EP0769554B1 (en) 2008-03-05
GR3026554T3 (en) 1998-07-31
EP0769554A3 (en) 1997-05-28
ATE388165T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
DK0477971T3 (da) Humant CNP gen og precursorprotein
IL131016A0 (en) Selection of proteins using rna-protein fusions
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
DE3884529D1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
DK1490386T3 (da) Nyt polypeptid og nukleinsyrer kodende for dette
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
DE3672924D1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
IL87647A0 (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
ATE262038T1 (de) Br96 mutantantikörper die mit menschlichen karzinomen reagieren
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0723016A3 (en) Leukocyte activation factor
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DE69127743D1 (de) Für ein Protein, das sich mit dem Enhancer des Alpha-Fetoprotein verbindet, kodierende DNS
ATE75255T1 (de) Peptid und dafuer kodierendes gen.
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins
ZA886593B (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.
ITRM920517A1 (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.